IATI Israel’s Life Science Annual Industry Report 2023-24

March 2024

IATI's report, in collaboration with PwC and the Israeli Innovation Authority, focuses on the four sub-sectors that make up the life sciences industry and presents various details and cross-sections relating to these sub-sectors. In addition, the report presents the government grants activity related to companies from the life sciences sector in 2023 and the programs relevant to these companies. The report also presents rising sectors that were identified as sectors with significant growth potential in the coming years. These sectors were identified by us together with the Israeli Innovation Authority and with leading investment funds, and together with the main sub-sectors constitute the growth engine of the life sciences industry in Israel. The spotlight is directed to these fields because their leading innovation and the multidisciplinary required in them, and they represent the capabilities and strength of the life sciences industry in Israel.

The report brings for the first time the results of a survey conducted by IATI among more than 20 leading venture capital funds. Despite the Iron Sword war and other factors that led to a decrease in the total fund raising in 2023, most funds do not believe that there will be a substantial change in their investment decisions in 2024 compared to the previous plan. Also, more than half of the funds replied that in 2024 they intend to have most of their investments in Israeli companies, while less than a quarter of them intend to invest less than 10% of their total investments in Israeli companies. Among the venture capital funds that participated in the survey: aMoon, Pontifax, Peregrine, Pitango, IBF, Vertex, NFX BIO, 10D, Entrée Capital, Sanara LionBird, eHealth, BRM, Tal, Amiti, Almeda, Biolight and more.

IATI Israel's Life-Science Annual Industry Report 2023-24 (English Full Report)

IATI Israel's Life Science Industry Report 2024 Executive Summary (Hebrew)

IATI Israel's Life Science Industry Report 2024 Executive Summary (English)

IATI Israeli HealthTech Venture Capital Funds Survey Q1 2024

The Report is currently available in translation to: Spanish, Chinese, French, Portuguese and Arabic.

The Report was translated by Q-lingua translation services - professional medical translation services.

For more information about their work, we invite you to check their Website, Facebook and LinkedIn.

IATI Israel's Life Science Industry Report 2024 Full Report (Spanish)

IATI Israel's Life Science Industry Report 2024 Full Report (Chinese)

IATI Israel's Life Science Industry Report 2024 Full Report (French)

IATI Israel's Life Science Industry Report 2024 Full Report (Portuguese)

IATI Israel's Life Science Industry Report 2024 Full Report (Arabic)

Stay Connected

To enjoy all of our latest updates
Come visit us
Become a Member
Skip to content